ArticleEuropean journal of radiology2020
Linear mixed-effects models for predicting sarcoma local recurrence growth rates: Implications for optimal surveillance imaging frequency.
Article in European journal of radiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
purposeSarcomas are rare tumours of mesenchymal origin that are often treated with surgical resection and radiation to prevent local recurrence (LR). Surveillance for LR after surgical resection is often done with contrast-enhanced MRI, however, the optimal frequency of surveillance imaging is unknown. The aims of this study are to calculate LR growth, and to evaluate the factors that affect LR growth and to use this data to predict the optimal imaging surveillance frequency.
methodRetrospective cohort study of patients with sarcoma who were treated at a tertiary care academic institution between 01/01/2007 and 01/03/2020 identified 34 patients with 60 histologically confirmed LRs. The maximum LR length was measured on each surveillance MRI. Linear mixed-effects models were used to calculate the maximum LR length growth rate. We evaluated whether age, sex, primary sarcoma tumour size, sarcoma grade, margins, chemotherapy or radiation therapy affected the growth rate of the maximum LR length.
resultsOne patient had 6 LRs (2.9 %), two patients (5.9 %) had 5 LRs, two patients (5.9 %) had 4 LRs, two patients (5.9 %) had 3 LRs, three patients (8.8 %) had 2 LRs, and twenty-four patients (70.6 %) had 1 LR. Most patients had high grade (Grade II/III) disease (88.2 %). 41.2 % of the patients had microscopically positive surgical margins. The median time (range) from surgery to LR was 264 days (17 - 8013) days, and 90 % occurred within 42.8 months (1284 days). Microscopically positive margins were associated with faster growth of the maximum LR length (P = 0.036). Assuming that a 1 cm sarcoma LR is actionable and that the previous surveillance MRI was negative, the data predicts that patients with microscopically positive margins should have surveillance MRIs every 6.2 months when LRs are expected to achieve a length of 1.0 cm (95 % CI (0.4-2.3 cm)).
conclusionsPatients with microscopically positive resection margins had LRs that grew faster than patients with negative margins. Surveillance imaging with contrast-enhanced MRI could be conservatively performed every 6 months when LRs are expected to be just less than 1.0 cm in length.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.